Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (161-170 of 397) with videos related to

Pageof 40
Sort By:
Nature Genetics|December 3, 2021
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancersTakahiro Ito, Michael J Young, Ruitong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.
Science (New York, N.Y.)|July 12, 2014
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityMin Yu, Aditya Bardia, Nicola Aceto, et al.
Cell Reports|September 8, 2021
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerAlok K Tewari, Alexander T M Cheung, Jett Crowdis, et al.
Nature Communications|February 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's MacroglobulinemiaRomanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory, et al.
Blood Advances|December 10, 2019
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasionKirsty Wienand, Bjoern Chapuy, Chip Stewart, et al.
Cancer Research|May 5, 2018
<i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine OsteosarcomaSharadha Sakthikumar, Ingegerd Elvers, Jaegil Kim, et al.
Research Square|April 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT studyIrene Ghobrial, Noe Perron, Michelle Aranha, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
Nature|January 25, 2023
Author Correction: The repertoire of mutational signatures in human cancerLudmil B Alexandrov, Jaegil Kim, Nicholas J Haradhvala, et al.
Pageof 40

Showing results (161-170 of 397) with videos related to

Sort By:
Pageof 40
Nature Genetics|December 3, 2021
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancersTakahiro Ito, Michael J Young, Ruitong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.
Science (New York, N.Y.)|July 12, 2014
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityMin Yu, Aditya Bardia, Nicola Aceto, et al.
Cell Reports|September 8, 2021
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerAlok K Tewari, Alexander T M Cheung, Jett Crowdis, et al.
Nature Communications|February 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's MacroglobulinemiaRomanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory, et al.
Blood Advances|December 10, 2019
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasionKirsty Wienand, Bjoern Chapuy, Chip Stewart, et al.
Cancer Research|May 5, 2018
<i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine OsteosarcomaSharadha Sakthikumar, Ingegerd Elvers, Jaegil Kim, et al.
Research Square|April 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT studyIrene Ghobrial, Noe Perron, Michelle Aranha, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
Nature|January 25, 2023
Author Correction: The repertoire of mutational signatures in human cancerLudmil B Alexandrov, Jaegil Kim, Nicholas J Haradhvala, et al.
Pageof 40